A recent study published in Aging-US found that feeling lonely, unhappy, or hopeless increases one's biological age more than smoking. The research used digital models of aging to analyze the effects of various factors on aging rates, revealing a significant correlation between mental health and accelerated aging.
Marco Quarta will present his latest research on the biology of aging at the world's largest aging research for drug discovery conference. The presentation focuses on single cell AI-enabled discovery of cellular senescence and targeted senolytic drug development.
Tyler Golato will present his latest research on the topic of Decentralized Science, focusing on early learnings and future hopes. The conference aims to discuss the most pressing obstacles in finding efficacious interventions for aging.
Joe Betts-LaCroix will present his latest research on reprogramming, parabiosis, and autophagy, exploring their commonalities in the context of aging biology. The conference aims to discuss the most pressing obstacles in finding efficacious interventions for aging.
Ann Beliën will present her latest research on Platform-based clinical development in aging at the 9th Aging Research & Drug Discovery conference. The conference aims to discuss the most pressing obstacles in finding efficacious interventions for aging, bringing together experts from academia and industry.
Dr. Varun Dwaraka will present his latest research on epigenetic clocks and their use as a diagnostic tool for various disease states, including aging. The presentation highlights recent clinical trial insights from the use of epigenetic clocks to test pharmacologic and clinical interventions.
Lou Hawthorne will present his latest research on clearing progeronic soluble factors using NaNots at the conference. The study aims to develop treatments for major diseases such as cancer and inflammatory conditions like sepsis and 'inflamm-aging'.
Ann Beliën, CEO and Founder of Rejuvenate Biomed, will present her latest research on platform-based clinical development in aging. Her company has evolved from a discovery company to a clinic stage company under her leadership with over 20 years of experience in drug development.
A new AI-powered mental health application, FuturSelf, uses machine learning to identify the shortest path to mental stability. The system offers personalized recommendations for improving long-term well-being.
Ian David Hickson will present his research on chromosome instability and its role in driving human disease, with a focus on developing novel therapeutic strategies to target difficult-to-treat cancers. The conference aims to bridge clinical, academic, and commercial research to find practical solutions to extending healthy lifespan.
Dr. Björn Schumacher will discuss his research on genome stability and its impact on aging and disease, using C. elegans as a model organism. His work aims to contribute to the development of future strategies to prevent age-related diseases.
João Pedro de Magalhães, a renowned expert in aging research, will present his latest work on data-driven approaches in longevity pharmacology. The presentation aims to bridge the gap between genotype and phenotype, a major challenge in understanding the ageing process.
Dr. Jennifer Garrison will present her latest research on Reframing Health and Aging through the Lens of Reproductive Longevity at the 9th ARDD conference. Her lab studies inter-tissue communication in systemic aging and its impact on female reproductive decline.
Dr. Kristen Fortney will present her research on data-informed drug discovery and clinical development for therapies targeting aging at the 9th Aging Research and Drug Discovery conference. The presentation aims to unlock opportunities to treat or prevent diseases of aging by targeting molecular pathways that impact healthy human aging.
Matthias Mann, Director of Proteomics and Signal Transduction at Max Planck Institute, presents latest research on Single cell and Deep Visual Proteomics for precision medicine. The conference focuses on accelerating aging research and discovery, with top-level speakers sharing groundbreaking research.
Dr. Tim R Peterson's research explores the molecular cause-and-effect between infectious disease and aging, identifying a shared biochemistry that drives senescent cell formation. The presentation highlights potential applications of FDA-approved drugs in developing novel senolytics.
Dr. Joris Deelen will present his latest research on identifying and functional characterizing genetic variants linked to human longevity. The work aims to understand the efficacy of previously identified biomarkers of aging in clinical studies, using omics-based approaches such as metabolomics.
Dr. Fabio Demontis will present his research on Myokine-based interventions to contrast muscle and brain aging at the 9th Aging Research & Drug Discovery Meeting 2022. His lab aims to understand how communication between skeletal muscle and the brain influences proteostasis as we age.
Dudley Lamming, a renowned expert in aging research, will present his latest findings on how specific dietary amino acids regulate health and longevity. His research aims to understand the molecular mechanisms underlying aging and potential interventions.
Global thought-leaders will share their insights into aging and its effects, with a focus on reducing age-associated morbidities and frailty. The conference aims to develop interventions that can slow down or reverse the aging process, benefiting everyone's health and lifespan.
Dr. Maria Carolina Florian will present her latest research on aging hematopoietic stem cells, challenging the concept that aging is an irreversible process. Her work aims to improve tissue homeostasis and regeneration by targeting epigenetic polarity and functionally rejuvenating aged HSCs.
Dr. Brian Kennedy will discuss his latest research on the path to longer lifespan and healthspan, highlighting potential smooth or bumpy routes to achieving healthy longevity. The conference aims to bring together experts to share groundbreaking research and developments in aging and drug discovery.
Dr. Anne-Ulrike Trendelenburg will present research on targeting common pathways to treat age-related diseases, including sarcopenia and premature aging diseases. The conference brings together experts from academia and industry to discuss progress in the molecular, cellular and organismal basis of aging.
Kai-Fu Lee will present his latest research on AI and its applications in healthcare at the 8th Aging Research & Drug Discovery Meeting. The conference aims to discuss the molecular, cellular, and organismal basis of aging and search for interventions.
Dr. Sibylle Jäger will present a new research on a salicylic acid derivative that prevents oxidative damage in skin, exploring its potential as an intervention for aging. The conference aims to discuss the latest progress in understanding the molecular basis of aging and finding interventions.
VitaDAO, a decentralized intellectual property collective, is funding early-stage longevity drug development. The conference will discuss novel approaches to funding aging research, with experts sharing their latest groundbreaking research.
Dr. Nir Barzilai will present his latest research on neurotherapeutics from genetic-based discovery in centenarians, focusing on designing and delivering treatment for every disease. The conference aims to bridge clinical, academic, and commercial research to find practical solutions for extending healthy lifespan.
Dr. Anne Brunet will present her latest research on mechanisms of brain aging and rejuvenation, focusing on novel genes regulating longevity and neural stem cell aging. The conference aims to bridge clinical, academic, and commercial research to develop practical solutions for extending the healthy lifespan of everyone.
Deep Longevity has adapted its blood aging clock to work with saliva samples, improving accuracy from 20.9 years to 4.7 years. The company's solution uses cell-type deconvolution to separate the composition of saliva samples.
A new educational curriculum in longevity medicine for physicians has been developed, outlining the benefits of promoting healthspan and lifespan. The course provides a comprehensive introduction to theoretical and practical basics of longevity medicine, including molecular mechanisms, biomarkers of aging, and geroprotector regimens.
Researchers explore the potential of rapalogs to improve vaccine response and outcomes in biologically aged individuals. The study suggests that geroprotectors, such as rapamycin, may enhance resilience against SARS-CoV-2 infection and reduce disease severity.
Researchers propose a new field of study converging AI, basic research, and medicine to extend human lifespan. The framework uses deep learning to predict age-related changes, enabling the development of a new field of medicine - longevity medicine.
DeepMAge is an epigenetic aging clock that accurately predicts human age on over 6,000 DNA methylation profiles, outperforming previous clocks. The clock reveals associations with various age-related conditions, including cancer, dementia, and obesity.
Deep Longevity will present research on deep aging clocks at the Kinexum webinar, combining leading researchers and a preeminent expert at the FDA to accelerate the use of aging biomarkers in therapeutic interventions. The company has developed multimodal biomarkers of aging using deep learning techniques.
Deep Longevity's 'longevity cloud' will track and analyze aging at multiple levels, providing a novel way to extend human productive longevity and improve performance. The combined company aims to create an end-to-end longevity ecosystem serving researchers, medical doctors, and enthusiasts worldwide.